Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
Tap, W.D., Wainberg, Z.A., Anthony, S.P., Ibrahim, P.N., Zhang, C., Healey, J.H., Chmielowski, B., Staddon, A.P., Cohn, A.L., Shapiro, G.I., Keedy, V.L., Singh, A.S., Puzanov, I., Kwak, E.L., Wagner, A.J., Von Hoff, D.D., Weiss, G.J., Ramanathan, R.K., Zhang, J., Habets, G., Zhang, Y., Burton, E.A., Visor, G., Sanftner, L., Severson, P., Nguyen, H., Kim, M.J., Marimuthu, A., Tsang, G., Shellooe, R., Gee, C., West, B.L., Hirth, P., Nolop, K., van de Rijn, M., Hsu, H.H., Peterfy, C., Lin, P.S., Tong-Starksen, S., Bollag, G.(2015) N Engl J Med 373: 428-437
- PubMed: 26222558 
- DOI: https://doi.org/10.1056/NEJMoa1411366
- PubMed Abstract: 
Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors. This observation has led to the discovery and clinical development of therapy targeting the CSF1 receptor (CSF1R).
Organizational Affiliation: 
From Memorial Sloan Kettering Cancer Center (W.D.T., J.H.H.) and Weill Cornell Medical College (W.D.T.) - both in New York; University of California, Los Angeles, Medical Center, Los Angeles (Z.A.W., B.C., A.S.S.), Plexxikon, Berkeley (P.N.I., C.Z., J.Z., G.H., Y.Z., E.A.B., G.V., L.S., P.S., H.N., M.J.K., A.M., G.T., R.S., C.G., B.L.W., P.H., K.N., H.H.H., P.S.L., S.T.-S., G.B.), and Stanford University School of Medicine, Stanford (M.R.) - all in California; Evergreen Hematology and Oncology, Spokane, WA (S.P.A.); University of Pennsylvania School of Medicine, Philadelphia (A.P.S.); Rocky Mountain Cancer Centers, Denver (A.L.C.); Dana-Farber Cancer Institute (G.I.S., A.J.W.) and Massachusetts General Hospital (E.L.K.) - both in Boston; Vanderbilt University Medical Center, Nashville (V.L.K., I.P.); Virginia G. Piper Cancer Center at Scottsdale Healthcare-Translational Genomics Research Institute (TGen), Scottsdale, AZ (D.D.V.H., G.J.W., R.K.R.); and Spire Sciences, Boca Raton, FL (C.P.).